Suppression of Recurrent Transient Ischemic Attacks by a Statin Agent
Neurol 56:531-532, Alberts,M.J., 2001
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001
Statins for Stroke Prevention?
Lancet 357:1548-1549, Sandercock,P., 2001
Clinical Characteristics of Pathologically Proved Cholesterol Emboli to the Brain
Neurol 54:1681-1683, Ezzeddine,M.A.,et al, 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Serum Lipids in Young Patients with Ischaemic Stroke: A Case-control Study
JNNP 69:29-33, Albucher,J.F. et al, 2000
Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000
Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000
An Overview of Acute Stroke Therapy
Arch Int Med 160:3196-3206, Fisher,M. & Schaebitz,W., 2000
Cholesterol and Strokes
BMJ 320:459-460, Oliver,M.F., 2000
Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999
Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999
Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999
Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999
Stroke Patterns of Internal Carotid Artery Dissection in 40 Patients
Stroke 29:2646-2648, Lucas,C.,et al, 1998
Effect of HMGcoA Reductase Inhibitors on Stroke, A Meta-Analysis of Controlled Trials
Ann Int Med 128:89-95, Bucher,H.C.,et al, 1998
Lovastatin for X-Linked Adrenoleukodystrophy
NEJM 339:702-703, Singh,I.,et al, 1998
HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998
Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997
High-Density Lipoprotein Cholesterol & Risk of Ischemic Stroke Mortality:21-Yr FU of 8586 Men-Israeli Ischemic Heart Dis Study
Stroke 28:83-87, Tanne,D.,et al, 1997
Cumulative Effects of High Cholesterol Levels, High Blood Pressure, & Cigarette Smoking on Carotid Stenosis
NEJM 337:516-522, Wilson,P.W.F.,et al, 1997
Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997
Epidemiology of Stroke
JNNP 61:333-338, Khaw,K.T., 1996
Reduction in Carotid Arterial Wall Thickness Using Lovastatin & Dietary Therapy
Ann Int Med 124:548-556, Hodis,H.N.,et al, 1996
Predictors of Stroke in Middle-Aged Patients with Non-Insulin-Dependent Diabetes
Stroke 27:63-68, Lehto,S.,et al, 1996
Clinicopath Conf
Tangier Disease, Case 16-1996, NEJM 334:1389-1394996., , 1996
Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996
Low Total Serum Cholesterol and Intracerebral Hemorrhagic Stroke:Is the Assoc Confined to Elderly Men
Stroke 27:1993-1998, Iribarren,C.,et al, 1996
Primary Prevention of Stroke
NEJM 333:1392-1400, Bronner,L.L.,et al, 1995
Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995
Vascular Outcome in Men with Asymptomatic Retinal Cholesterol Emboli
Ann Int Med 122:249-253, Bruno,A.,et al, 1995
Peripheral Neuropathy with Bezafibrate
BMJ 309:929, Ellis,C.J.,et al, 1994
Neuropathy Associated with Hyperlipidemia
Neurol 44:2185-2186, McManis,P.G.,et al, 1994
Failure of Aspirin Treatment After Stroke
Stroke 25:275-277, Bornstein,N.M.,et al, 1994
Atheromatous Embolism in the Brain:A Clinicopath Analysis of 15 Autopsy Cases
Neurol 44:1231-1237, Masuda,J.,et al, 1994
HMG-CoA Reductase Inhibitor Therapy and Peripheral Neuropathy
Ann Int Med 120:970, Jacobs,M.B., 1994
Risk Factors for Cervical Atherosclerosis in patients with Transient Ischemic Attack or Minor Ischemic Stroke
Stroke 24:970-975, Palomaki,H.,et al, 1993
Cholesterol Reduction and the Risk for Stroke in Men, A Meta-Analysis of Randomized, Controlled Trials
Ann Int Med 119:136-145, Atkins,D.,et al, 1993
Serum Lipid Levels During Carbamazepine Medication
Arch Neurol 50:590-593, Isojarvi,J.I.T.,et al, 1993
One-Year Reduction and Longitudinal Analysis of Carotid Intima-Media Thickness Associated with Colestipol/Niacin Therapy
Stroke 24:1779-1783, Mack,W.J.,et al, 1993
Transeophageal Echocardiographic Detection of Aortic Arch Disease in Patients with Cerebral Infarction
Stroke 23:1005-1009, Amarenco,P.,et al, 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
Lioporotein and Apolipoprotein Profile in Men with Ischemic Stroke
Stroke 23:1556-1562, Pedro-Botet,J.,et al, 1992
Cholesterol Emboli Neuropathy
Neurol 42:428-430, Bendixen,B.H.,et al, 1992
Serum Cholesterol Concentration and Risk of Primary Brain Tumours
BMJ 302:90, Knekt,P.,et al, 1991
Gemfibrozil-Induced Myopathy
Arch Int Med 151:1873-1874, Magarian,G.J.,et al, 1991
Cholesterol-Lowering Agent Myopathy (CLAM)
Neurol 41:1159-1160, London,S.F.,et al, 1991
Fibrinogen and Lipid Concentrations as Risk Factors for Transient Ischemic Attacks & Minor Ischaemic Strokes
BMJ 303:605-609, Qizilbash,N.,et al, 1991
Lacunar Infarctions Due to Cholesterol Emboli
Stroke 22:1440-1444, Laloux,P.&Brucher,J., 1991
Clinicopath Conf
Renal Cholesterol Embolism (after CABG) , Case 2-1991, NEJM 324:113-1201., , 1991